Evonik is a leading specialty chemicals company.
Profitable growth and a sustained increase in the value of the company
form the heart of itsstrategy, which is supported by its owners,
RAG-Stiftung (74.99 percent) and funds managed by CVC Capital Partners
(25.01 percent). Evonik's specialty chemicals activities focus on
high-growth megatrends—especially health, nutrition, resource
efficiency, and globalization—and Evonik's goal is to enter attractive
future-oriented markets. Click on the image to visit the Evonik website.